Clinical Trials in Baltimore

Showing 14181-14200 of 20,142 trials

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01118052

This phase II trial studies the side effects and how well EGEN-001 works in treating patients with ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer that is persistent or has come back. Biological therapies, such as EGEN-001, use substances made from living organisms that may stimulate or suppress the immune system in different ways and stop tumor cells from growing.

Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma

Gynecologic Oncology Group22 participantsStarted Nov 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +8 more locations

COMPLETEDPhase 3< 1 mile

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

NCT00040183

The purpose of this study is to determine if OSI-774 will improve overall survival when combined with a standard dose of the chemotherapy drug gemcitabine, to individuals with pancreatic cancer.

Pancreatic Cancer

OSI Pharmaceuticals569 participantsStarted Nov 2001

Tucson, Arizona, United States • Springdale, Arkansas, United States • Berkeley, California, United States +137 more locations

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Find Trials by Condition in Baltimore

Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia

Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities

Simvastatin Therapy for Moderate and Severe COPD

YM443 in Subjects With Functional Dyspepsia

Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation

Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation

Condition of Approval Study

Decision Aid - Extreme Prematurity

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Alendronate to Prevent Loss of Bronchoprotection in Asthma

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study